Latest Administration News

Bioxyne Limited has raised its FY2025 revenue forecast to $25 million, driven by a remarkable 267% increase in first-half revenue and strong momentum from its subsidiary Breathe Life Sciences.

Regional Express Holdings has completed the transfer of debt from PAGAC Regulus Holding to the Commonwealth of Australia, marking a key step in its ongoing administration process.

InhalerX Limited reported a negative cash flow for the December quarter despite securing a substantial $38.5 million funding facility aimed at advancing its clinical trials. The company has yet to draw on this facility, maintaining a cautious cash position as it progresses its drug development programs.

Regional Express Holdings has assigned a $50 million portion of its debt to the Commonwealth of Australia, making the government the largest secured creditor as the airline navigates voluntary administration.

Vonex Limited reported a net cash inflow of $779,000 from operating activities in Q4 2024, maintaining a solid cash position despite accelerated debt repayments following a change of control.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

The Calmer Co. International Limited has reported a remarkable surge in sales and cash receipts for the first half of FY25, exceeding the entire FY24 sales. Alongside a strategic CEO transition and factory upgrade, the company is sharpening its focus on profitable growth and cost control.

Forbidden Foods Limited has more than doubled its group revenues in Q2 FY25 following the acquisition of Oat Milk Goodness, driven by expanded retail distribution and strong ecommerce growth.

Insignia Financial reported a robust 2.2% increase in Funds Under Management and Administration to $326.8 billion in 2Q25, underpinned by strong net inflows and strategic milestones including the IT separation from NAB and the unveiling of its Vision2030 growth strategy.

Praemium Limited reports a solid Q2 FY25 performance, with Funds Under Administration rising 4% to $30.2 billion and net inflows surging to $371 million, driven by strong momentum in its SMA and Powerwrap platforms.

Praemium has reported a record 29% increase in total Australian funds under administration (FUA) to $62.1 billion in Q2 FY2025, driven by strong net inflows and the successful launch of its next-generation IDPS, Spectrum.

Netwealth Group Limited has reported a record $4.5 billion in net inflows for the December 2024 quarter, marking a 69.8% increase year-on-year and driving its funds under administration past $100 billion.